GPFT (Grapefruit USA) Debt-to-EBITDA : -11.58 (As of Sep. 2023)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

What is Grapefruit USA Debt-to-EBITDA?

Grapefruit USA GPFT -16.67% Debt-to-EBITDA is -11.58 as of Sep. 2023.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Grapefruit USA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $4.95 Mil. Grapefruit USA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.00 Mil. Grapefruit USA's annualized EBITDA for the quarter that ended in Sep. 2023 was $-0.43 Mil. Grapefruit USA's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was -11.57.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Grapefruit USA's Debt-to-EBITDA or its related term are showing as below:

GPFT's Debt-to-EBITDA is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 1.68
* Ranked among companies with meaningful Debt-to-EBITDA only.

Grapefruit USA (OTCPK:GPFT) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Grapefruit USA Debt-to-EBITDA Related Terms

Grapefruit USA Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Grapefruit USA's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grapefruit USA Debt-to-EBITDA Chart

Grapefruit USA Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Debt-to-EBITDA

Get a 7-Day Free Trial

0.26

-0.29

-0.80

-23.68

-2.61

Grapefruit USA Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Sep23
Debt-to-EBITDA	Get a 7-Day Free Trial															5.39	-75.85	-1.47	-23.17	-11.58

GPFT vs KAYS, KOAN, MJNE: Debt-to-EBITDA Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grapefruit USA's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grapefruit USA Debt-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grapefruit USA's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Grapefruit USA's Debt-to-EBITDA falls into.

Save Embed

Grapefruit USA Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Grapefruit USA's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(4.703	+	0.927)	/	-2.156
	=	-2.61

Grapefruit USA's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(4.954	+	0)	/	-0.428
	=	-11.57

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2023) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →

What does a Debt-to-EBITDA of -11.58 mean?

Grapefruit USA (GPFT) has a Debt-to-EBITDA of -11.58 as of Sep. 2023. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Grapefruit USA.

Is Grapefruit USA's Debt-to-EBITDA too high?

Grapefruit USA's current Debt-to-EBITDA is -11.58.

How does Grapefruit USA's Debt-to-EBITDA compare to KAYS and KOAN?

Grapefruit USA's Debt-to-EBITDA of -11.58 can be compared against companies in the Drug Manufacturers industry. The industry median Debt-to-EBITDA is 1.68. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Debt-to-EBITDA for a Drug Manufacturers company?

The median Debt-to-EBITDA among Drug Manufacturers companies is 1.68, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Debt-to-EBITDA mean?

A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Grapefruit USA. For the Drug Manufacturers industry, the median Debt-to-EBITDA is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grapefruit USA's current Debt-to-EBITDA is -11.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Grapefruit USA stock overvalued right now?

Grapefruit USA (GPFT) has a current Debt-to-EBITDA of -11.58. The current Debt-to-EBITDA is -11.58. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Debt-to-EBITDA calculated?

Debt-to-EBITDA is calculated from a company's financial statements. For Grapefruit USA (GPFT), the current Debt-to-EBITDA is -11.58 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grapefruit USA Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies KAYS KOAN MJNE LRSV CSTF STMH KGKG CBDY CANB GCAN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX

Address 10850 Wilshire Boulevard, Suite 710, Los Angeles, CA, USA, 90024

Website https://www.grapefruitblvd.com

Grapefruit USA Inc currently has no operations. It is actively seeking a strategic merger partner with the goal of completing a business combination.